Comparison between Nitesh Estates IPO and Parabolic Drugs IPO.
Nitesh Estates IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Parabolic Drugs IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Nitesh Estates IPO is up to ₹405.00 Cr whereas the issue size of the Parabolic Drugs IPO is up to ₹200.00 Cr. The final issue price of Nitesh Estates IPO is ₹54.00 per share and of Parabolic Drugs IPO is ₹75.00 per share.
| Nitesh Estates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹54.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹56.00 per share | ₹85.00 per share |
| Issue Price (Final) | ₹54.00 per share | ₹75.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 100 shares | 80 shares |
| Fresh Issue Size | 7,50,00,000 shares | 2,46,40,965 shares |
| Fresh Issue Size (Amount) | up to ₹405.00 Cr | up to ₹184.81 Cr |
| OFS Issue Size | 0 shares | 20,25,702 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹15.19 Cr |
| Issue Size Total | 7,50,00,000 shares | 2,66,66,667 shares |
| Issue Size Total (Amount) | up to ₹405.00 Cr | up to ₹200.00 Cr |
Nitesh Estates IPO opens on Apr 23, 2010, while Parabolic Drugs IPO opens on Jun 14, 2010. The closing date of Nitesh Estates IPO and Parabolic Drugs IPO is Apr 27, 2010, and Jun 17, 2010, respectively.
| Nitesh Estates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Apr 22, 2010 | |
| Issue Open | Apr 23, 2010 | Jun 14, 2010 |
| Issue Close | Apr 27, 2010 | Jun 17, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 13, 2010 | Jul 01, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Nitesh Estates IPO P/E ratio is , as compared to Parabolic Drugs IPO P/E ratio of .
| Nitesh Estates IPO | Parabolic Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 84.11 | 63.21 | ||||
| Promoter Shareholding (Post-Issue) | 40.86 | 38.04 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹787.49 Cr. | ₹464.19 Cr. | ||||
| ROE | ||||||
| ROCE | 6.21 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 5.3 | 19.96 |
In the Nitesh Estates IPO Retail Individual Investors (RII) are offered 2,62,50,000 shares while in Parabolic Drugs IPO retail investors are offered 2,62,50,000 shares. Qualified Institutional Buyers (QIB) are offered 2,66,51,800 shares in Nitesh Estates IPO and 1,30,83,333 shares in Parabolic Drugs IPO.
| Nitesh Estates IPO | Parabolic Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,08,48,200 shares | |
| Market Maker Reservation | ||
| QIB | 2,66,51,800 shares | 1,30,83,333 shares |
| NII | 1,12,50,000 shares | 39,25,000 shares |
| RII | 2,62,50,000 shares | 91,58,334 shares |
| Employee | 5,00,000 shares | |
| Others | ||
| Total | 7,50,00,000 shares | 2,66,66,667 shares |
Nitesh Estates IPO subscribed 0.99x in total, whereas Parabolic Drugs IPO subscribed 1.04x.
| Nitesh Estates IPO | Parabolic Drugs IPO | |
|---|---|---|
| QIB (times) | 2.54x | 1.48x |
| NII (times) | 0.22x | 1.20x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.16x | 0.40x |
| Employee (times) | 0.11x | |
| Other (times) | ||
| Total (times) | 0.99x | 1.04x |
